EU launches plan to increase production of vaccines against Kovid-19

NS US government To invest billions of dollars in pharmaceutical companies Increase in production of vaccines against Kovid-19, looking forward to a supply of one billion additional injections each year to share with the rest of the world.

According to the new initiative, Biomedical Research and Development Authority of the Department of Health and Human Services Ask pharmaceutical companies that have demonstrated the ability to produce Vaccunus mRNA Apply for public investment to increase your manufacturing capacity. In the United States, companies pfizer and modern They are the two that produce mRNA vaccines.

The government anticipates that increasing manufacturing capacity will help address global vaccine shortages, especially in low- and middle-income countries, which in turn will prevent deaths and the emergence of more dangerous forms of the virus.

Agreements with Moderna or Pfizer have yet to be finalized, but the US government expects the companies’ facilities, equipment, training and personnel support to result in more manufacturing capacity and enough to be shared by mid-2222. The dosage will be other countries and to prepare for the next global health emergency.

The announcement was released Wednesday by an official in President Biden’s administration, who spoke on condition of anonymity because he was not authorized to speak about it before the official announcement. The news was first reported by the newspaper the new York Times.

mg